Nautilus Biotechnology (NAUT) Other Non Operating Income (2021 - 2026)
Nautilus Biotechnology (NAUT) posted Other Non Operating Income of -$13000.0 for Q2 2026, up 18.75% sequentially from -$16000.0 in Q2 2025, and up 18.75% YoY from -$10947.4 in Q2 2025.
Nautilus Biotechnology (NAUT) Other Non Operating Income (2021 - 2026) Analysis & Trends
Nautilus Biotechnology has reported Other Non Operating Income for 5 years, with the latest figure at -$13000.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Nautilus Biotechnology | 114.43 Mn | 114.43 Mn | 175,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Sep 30, 2022 | -132,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Sep 30, 2021 | -72,000.00 |